NL7402754A - - Google Patents

Info

Publication number
NL7402754A
NL7402754A NL7402754A NL7402754A NL7402754A NL 7402754 A NL7402754 A NL 7402754A NL 7402754 A NL7402754 A NL 7402754A NL 7402754 A NL7402754 A NL 7402754A NL 7402754 A NL7402754 A NL 7402754A
Authority
NL
Netherlands
Application number
NL7402754A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH351873A external-priority patent/CH575921A5/de
Application filed filed Critical
Publication of NL7402754A publication Critical patent/NL7402754A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NL7402754A 1973-03-09 1974-02-28 NL7402754A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH351873A CH575921A5 (en) 1973-03-09 1973-03-09 Pyrrolylphenoxy propanolamine derivs - with anti-excitatory and adrenergic beta-receptor blocking activity
CH142774 1974-02-01

Publications (1)

Publication Number Publication Date
NL7402754A true NL7402754A (xx) 1974-09-11

Family

ID=25687625

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7402754A NL7402754A (xx) 1973-03-09 1974-02-28

Country Status (19)

Country Link
US (1) US3984436A (xx)
JP (1) JPS5821623B2 (xx)
AR (2) AR204241A1 (xx)
CA (1) CA1029732A (xx)
DD (1) DD110493A5 (xx)
DE (1) DE2409313C2 (xx)
DK (1) DK153837C (xx)
ES (1) ES424021A1 (xx)
FR (1) FR2220266B1 (xx)
GB (1) GB1465783A (xx)
HK (1) HK1880A (xx)
HU (1) HU169465B (xx)
IE (1) IE38950B1 (xx)
IL (1) IL44293A (xx)
LU (1) LU69589A1 (xx)
MY (1) MY8000225A (xx)
NL (1) NL7402754A (xx)
SE (1) SE398230B (xx)
YU (5) YU39718B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4096331A (en) * 1976-12-28 1978-06-20 A. H. Robins Company, Incorporated 1-Substituted-3-aminoethoxypyrrolidines
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
DE3714485A1 (de) * 1987-04-30 1988-11-17 Bayer Ag Pyrrolophenylalkanolamine und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
DE3727114A1 (de) * 1987-08-14 1989-02-23 Basf Ag Verfahren zur herstellung von pyrrolen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2986564A (en) * 1959-02-20 1961-05-30 Rips Richard Pyrrole compounds
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
AR204241A1 (es) 1975-12-10
HU169465B (xx) 1976-11-28
CA1029732A (en) 1978-04-18
YU285881A (en) 1983-09-30
DE2409313C2 (de) 1986-10-16
IE38950L (en) 1974-09-09
YU286081A (en) 1983-09-30
LU69589A1 (xx) 1976-02-04
AU6638174A (en) 1975-09-11
IE38950B1 (en) 1978-07-05
FR2220266B1 (xx) 1977-11-10
HK1880A (en) 1980-01-18
YU43506B (en) 1989-08-31
YU42006B (en) 1988-04-30
JPS49125356A (xx) 1974-11-30
YU286181A (en) 1983-09-30
YU42005B (en) 1988-04-30
YU286281A (en) 1983-09-30
US3984436A (en) 1976-10-05
GB1465783A (en) 1977-03-02
DK153837C (da) 1989-01-30
DE2409313A1 (de) 1974-09-12
YU60374A (en) 1982-08-31
YU42027B (en) 1988-04-30
IL44293A0 (en) 1974-05-16
FR2220266A1 (xx) 1974-10-04
ES424021A1 (es) 1977-01-01
SE398230B (sv) 1977-12-12
MY8000225A (en) 1980-12-31
DK153837B (da) 1988-09-12
DD110493A5 (xx) 1974-12-20
YU39718B (en) 1985-04-30
IL44293A (en) 1978-08-31
JPS5821623B2 (ja) 1983-05-02
AR202495A1 (es) 1975-06-13

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU471343B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AR201229Q (xx)
AU472848B2 (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
AR201432A1 (xx)
AU471461B2 (xx)
AU447540B2 (xx)
AU476873B1 (xx)
AR210729A1 (xx)
AU477824B2 (xx)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed